• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例自行缓解的库欣病病例。

A Case of Spontaneously Resolving Cushing Disease.

作者信息

O'Brolchain Aongus, Ryder Simon, Berkman Kathryn

机构信息

Logan Endocrine and Diabetes Service, Meadowbrook Medical Centre, Meadowbrook, QLD 4131, Australia.

Griffith University, 58 Parklands Drive, Southport, QLD 4215, Australia.

出版信息

JCEM Case Rep. 2025 Jul 10;3(8):luaf131. doi: 10.1210/jcemcr/luaf131. eCollection 2025 Aug.

DOI:10.1210/jcemcr/luaf131
PMID:40642336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12241795/
Abstract

We report a case of spontaneous resolution of Cushing disease (CD). A 20-year-old female individual, previously healthy, was referred for investigation of galactorrhea and a prolactin level of 31 ng/mL (<20 ng/mL) (SI: 31 µg/L, <20 µg/L). A magnetic resonance imaging (MRI) scan revealed an 11 mm pituitary lesion. Cabergoline was commenced to address symptomatic hyperprolactinemia. Over the following months, signs of hypercortisolism evolved. Initial tests revealed a positive 1-mg dexamethasone suppression test (DST), prompting further evaluation. Midnight salivary and 24-hour urinary free cortisol tests confirmed hypercortisolism, consistent with a pituitary source which was confirmed with a peripheral corticotropin-releasing hormone (CRH) stimulation test. While cabergoline successfully resolved the galactorrhea, an MRI scan 6 months later showed an increase in the pituitary lesion's size, leading to neurosurgical referral. However, a preoperative MRI surprisingly revealed complete resolution of the pituitary mass, which coincided with the normalization of hypercortisolism symptoms and laboratory results. This rare case of spontaneous remission, while possibly influenced by cabergoline or undetected pituitary apoplexy, contributes valuable insights into the unpredictable nature of CD and its treatment.

摘要

我们报告一例库欣病(CD)自发缓解的病例。一名20岁的女性,既往健康,因溢乳及催乳素水平为31 ng/mL(<20 ng/mL)(国际单位制:31 μg/L,<20 μg/L)而前来接受检查。磁共振成像(MRI)扫描显示垂体有一个11毫米的病变。开始使用卡麦角林治疗症状性高催乳素血症。在接下来的几个月里,出现了皮质醇增多症的体征。最初的检查显示1毫克地塞米松抑制试验(DST)呈阳性,促使进一步评估。午夜唾液和24小时尿游离皮质醇检测证实存在皮质醇增多症,与垂体来源一致,外周促肾上腺皮质激素释放激素(CRH)刺激试验也证实了这一点。虽然卡麦角林成功解决了溢乳问题,但6个月后的MRI扫描显示垂体病变大小增加,导致转诊至神经外科。然而,术前MRI令人惊讶地显示垂体肿块完全消退,这与皮质醇增多症症状和实验室检查结果的正常化同时出现。这一罕见的自发缓解病例,虽然可能受卡麦角林或未被发现的垂体卒中影响,但为CD的不可预测性及其治疗提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbb/12241795/7434d7ed3c7b/luaf131f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbb/12241795/177cc7a3e53f/luaf131f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbb/12241795/7434d7ed3c7b/luaf131f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbb/12241795/177cc7a3e53f/luaf131f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbb/12241795/7434d7ed3c7b/luaf131f2.jpg

相似文献

1
A Case of Spontaneously Resolving Cushing Disease.一例自行缓解的库欣病病例。
JCEM Case Rep. 2025 Jul 10;3(8):luaf131. doi: 10.1210/jcemcr/luaf131. eCollection 2025 Aug.
2
Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.蝶窦异位促肾上腺皮质激素分泌垂体腺瘤:经鼻内镜切除术病例报告及文献系统综述
Neurosurg Focus. 2015 Feb;38(2):E10. doi: 10.3171/2014.10.FOCUS14685.
3
A Study of Adrenal Incidentaloma-Related Hormonal Assays After First Integration of the Diagnosis Within Primary Healthcare.基层医疗首次确诊肾上腺偶发瘤后相关激素检测的研究
Diseases. 2025 May 26;13(6):169. doi: 10.3390/diseases13060169.
4
Adrenocortical carcinoma during pregnancy.妊娠期肾上腺皮质癌
Endokrynol Pol. 2025;76(3):229-235. doi: 10.5603/ep.104445.
5
Cushing's disease: current medical therapies and molecular insights guiding future therapies.库欣病:当前的医学治疗方法及指导未来治疗的分子见解。
Neurosurg Focus. 2015 Feb;38(2):E11. doi: 10.3171/2014.10.FOCUS14700.
6
Ectopic Corticotropin-Releasing Hormone/Adrenocorticotropic Hormone-Co-Secreting Neuroendocrine Tumors Leading to Cushing's Disease: A Case Presentation and Literature Review.导致库欣病的异位促肾上腺皮质激素释放激素/促肾上腺皮质激素共同分泌神经内分泌肿瘤:病例报告及文献综述
Neuroendocrinology. 2025;115(6-7):576-588. doi: 10.1159/000544727. Epub 2025 Feb 14.
7
Giant Prolactin-Secreting Pituitary Adenoma: A Case Report and Literature Review.巨大泌乳素分泌型垂体腺瘤:一例报告及文献复习
Cureus. 2025 May 31;17(5):e85126. doi: 10.7759/cureus.85126. eCollection 2025 May.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Pituitary Apoplexy in a Child with Short Stature and Possible Recent SARS-CoV-2 Infection.一名身材矮小且近期可能感染新型冠状病毒的儿童发生垂体卒中。
Diagnostics (Basel). 2025 Jun 7;15(12):1453. doi: 10.3390/diagnostics15121453.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Cushing's syndrome update: 100 years after Minnie G.库欣综合征最新进展:米妮·G. 之后的100年
J Neuroendocrinol. 2022 Aug;34(8):e13167. doi: 10.1111/jne.13167. Epub 2022 Aug 18.
2
Spontaneous remission of Cushing's disease: A systematic review.库欣病自发缓解:系统评价。
Ann Endocrinol (Paris). 2021 Dec;82(6):613-621. doi: 10.1016/j.ando.2021.10.002. Epub 2021 Oct 21.
3
Consensus on diagnosis and management of Cushing's disease: a guideline update.库欣病的诊断和治疗共识:指南更新。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20.
4
Effectiveness of Medical Treatment of Cushing's Disease: A Systematic Review and Meta-Analysis.库欣病治疗效果的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Sep 17;12:732240. doi: 10.3389/fendo.2021.732240. eCollection 2021.
5
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.库欣病的治疗:当前和近期临床试验概述。
Front Endocrinol (Lausanne). 2020 Dec 8;11:648. doi: 10.3389/fendo.2020.00648. eCollection 2020.
6
Treatment of Pituitary and Other Tumours with Cabergoline: New Mechanisms and Potential Broader Applications.卡麦角林治疗垂体和其他肿瘤:新机制和潜在更广泛的应用。
Neuroendocrinology. 2020;110(6):477-488. doi: 10.1159/000504000. Epub 2019 Oct 10.
7
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY.垂体卒中的罕见病因:卡麦角林治疗
Acta Endocrinol (Buchar). 2018 Jan-Mar;14(1):113-116. doi: 10.4183/aeb.2018.113.
8
Cabergoline for Cushing's disease: a large retrospective multicenter study.卡麦角林治疗库欣病:一项大型回顾性多中心研究。
Eur J Endocrinol. 2017 Mar;176(3):305-314. doi: 10.1530/EJE-16-0662. Epub 2016 Dec 22.
9
Pituitary Apoplexy due to the Diagnostic Test in a Cushing"s Disease Patient.库欣病患者因诊断性检查导致垂体卒中
Turk Neurosurg. 2018;28(2):323-325. doi: 10.5137/1019-5149.JTN.16730-15.1.
10
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.卡麦角林治疗库欣病的价值有限:20 例患者 6 周治疗的前瞻性研究。
Eur J Endocrinol. 2016 Jan;174(1):17-24. doi: 10.1530/EJE-15-0807.